Skip to content
  1. Home/
  2. Latest news/
  3. Johnson & Johnson named a 2025 Fortune World’s Most Admired Company
johnson-johnson-named-a-2025-fortune-worlds-most-admired-company-0125.png

Johnson & Johnson named a 2025 Fortune World’s Most Admired Company

A dedication to innovation and social responsibility are just two of the qualities that helped the company garner a coveted spot on the list for the 23rd year in a row.

Johnson & Johnson’s purpose is to blend heart, science and ingenuity to profoundly impact health for humanity. Now the company is being recognized for this work, landing a spot on Fortune’s World’s Most Admired Companies list for 23 consecutive years.

What it takes to be a Most Admired Company

To compile the prestigious list, Fortune—in collaboration with consulting firm Korn Ferry (which has conducted the research for the World’s Most Admired Companies list since 1997)—asked more than 3,300 executives to rate the reputation of companies in their respective industries based on nine attributes. Those include a firm’s effectiveness in conducting business globally, social responsibility, innovativeness, value as a long-term investment and ability to attract and retain talented people, among other criteria.

On all of the above, Johnson & Johnson more than delivers.

A focus on health and care

In 2024, Johnson & Johnson continued its exclusive focus on healthcare. The company’s Innovative Medicine and MedTech businesses remain dedicated to tackling the world’s toughest health challenges, whether through the development of breakthrough treatments for today’s most complex diseases or innovating at the intersection of biology and technology.

Johnson & Johnson is honored to once again be among Fortune’s World’s Most Admired Companies.

More from Johnson & Johnson

Johnson & Johnson named to Fortune’s 2025 America’s Most Innovative Companies list

The company’s commitment to developing solutions that tackle the world’s most pressing health challenges has helped Johnson & Johnson be recognized as the top-ranked healthcare company on the list.

Inside Johnson & Johnson’s decades-long quest to develop effective treatments for IBD

Inflammatory bowel disease doesn’t have a cure—yet. But the recent FDA approval of a promising medication is the latest in a long line of treatments from Johnson & Johnson that are helping patients with IBD.

The future of immunology

Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.